CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate threat of new entrants
3.3.3. Moderate threat of substitutes
3.3.4. Moderate intensity of rivalry
3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in number of surgical procedures
3.4.1.2. Growing awareness regarding blood donations.
3.4.1.3. Rise in use of plasma derived albumin in drug development
3.4.2. Restraints
3.4.2.1. Stringent government regulations
3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets
CHAPTER 4: ALBUMIN MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Human Serum Albumin
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Bovine Serum Albumin
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Recombinant Albumin
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: ALBUMIN MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Therapeutics
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Drug Formulation and Vaccines
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Component of Media
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Other
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: ALBUMIN MARKET, BY SALES CHANNEL
6.1. Overview
6.1.1. Market size and forecast
6.2. B2C
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. B2B
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.3.4. B2B Albumin Market by Type
6.3.4.1. Pharmaceutical Applications Albumin Market by Type
6.3.4.2. Non Pharmaceutical Applications Albumin Market by Type
CHAPTER 7: ALBUMIN MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Type
7.2.3. Market size and forecast, by Application
7.2.4. Market size and forecast, by Sales Channel
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Type
7.2.5.1.2. Market size and forecast, by Application
7.2.5.1.3. Market size and forecast, by Sales Channel
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Type
7.2.5.2.2. Market size and forecast, by Application
7.2.5.2.3. Market size and forecast, by Sales Channel
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Type
7.2.5.3.2. Market size and forecast, by Application
7.2.5.3.3. Market size and forecast, by Sales Channel
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Type
7.3.3. Market size and forecast, by Application
7.3.4. Market size and forecast, by Sales Channel
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Type
7.3.5.1.2. Market size and forecast, by Application
7.3.5.1.3. Market size and forecast, by Sales Channel
7.3.5.2. France
7.3.5.2.1. Market size and forecast, by Type
7.3.5.2.2. Market size and forecast, by Application
7.3.5.2.3. Market size and forecast, by Sales Channel
7.3.5.3. UK
7.3.5.3.1. Market size and forecast, by Type
7.3.5.3.2. Market size and forecast, by Application
7.3.5.3.3. Market size and forecast, by Sales Channel
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Type
7.3.5.4.2. Market size and forecast, by Application
7.3.5.4.3. Market size and forecast, by Sales Channel
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Type
7.3.5.5.2. Market size and forecast, by Application
7.3.5.5.3. Market size and forecast, by Sales Channel
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Type
7.3.5.6.2. Market size and forecast, by Application
7.3.5.6.3. Market size and forecast, by Sales Channel
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Type
7.4.3. Market size and forecast, by Application
7.4.4. Market size and forecast, by Sales Channel
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by Type
7.4.5.1.2. Market size and forecast, by Application
7.4.5.1.3. Market size and forecast, by Sales Channel
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by Type
7.4.5.2.2. Market size and forecast, by Application
7.4.5.2.3. Market size and forecast, by Sales Channel
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by Type
7.4.5.3.2. Market size and forecast, by Application
7.4.5.3.3. Market size and forecast, by Sales Channel
7.4.5.4. Australia
7.4.5.4.1. Market size and forecast, by Type
7.4.5.4.2. Market size and forecast, by Application
7.4.5.4.3. Market size and forecast, by Sales Channel
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by Type
7.4.5.5.2. Market size and forecast, by Application
7.4.5.5.3. Market size and forecast, by Sales Channel
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Type
7.4.5.6.2. Market size and forecast, by Application
7.4.5.6.3. Market size and forecast, by Sales Channel
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Type
7.5.3. Market size and forecast, by Application
7.5.4. Market size and forecast, by Sales Channel
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Type
7.5.5.1.2. Market size and forecast, by Application
7.5.5.1.3. Market size and forecast, by Sales Channel
7.5.5.2. Saudi Arabia
7.5.5.2.1. Market size and forecast, by Type
7.5.5.2.2. Market size and forecast, by Application
7.5.5.2.3. Market size and forecast, by Sales Channel
7.5.5.3. South Africa
7.5.5.3.1. Market size and forecast, by Type
7.5.5.3.2. Market size and forecast, by Application
7.5.5.3.3. Market size and forecast, by Sales Channel
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Market size and forecast, by Type
7.5.5.4.2. Market size and forecast, by Application
7.5.5.4.3. Market size and forecast, by Sales Channel
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Merck KGaA
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.2. Sartorius AG
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. Octapharma AG
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.3.7. Key strategic moves and developments
9.4. Thermo Fisher Scientific Inc.
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.5. Ventria Bioscience Inc.
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.6. Grifols, S.A.
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.6.7. Key strategic moves and developments
9.7. CSL
9.7.1. Company overview
9.7.2. Key executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.8. China Biologic Products Holdings, Inc
9.8.1. Company overview
9.8.2. Key executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.9. Lazuline Bio
9.9.1. Company overview
9.9.2. Key executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.10. Takeda Pharmaceutical Company Limited
9.10.1. Company overview
9.10.2. Key executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
9.10.7. Key strategic moves and developments
| ※参考情報 アルブミンは、血液中に存在する主要なタンパク質の一種で、特に肝臓で合成される重要な成分です。アルブミンは血漿中に豊富に存在し、体内のさまざまな機能を果たしています。一般的に、アルブミンは低分子量の酸性タンパク質であり、分子量は約66,500ダルトンです。このタンパク質は主に血液の浸透圧を維持し、体液のバランスや栄養素の運搬に寄与しています。 アルブミンにはいくつかの種類がありますが、主要なものはヒトアルブミンです。ヒトアルブミンは、ヒト血漿中で約60％のタンパク質を占めており、その役割は非常に多岐にわたります。また、アルブミンは動物由来のもの（例えばウマアルブミンやブタアルブミン）や、植物由来のものもありますが、医療用にはヒト由来のアルブミンが特に重要視されています。 アルブミンの用途は非常に広範です。主な用途の一つは、血液製剤としての使用です。特に、肝不全や重度の火傷、手術後のショック状態など、血液中のアルブミン濃度が低下する病態に対して補充が行われます。アルブミン製剤は、血漿中の浸透圧を維持することで、体液のバランスを回復させる効果があります。これにより、腎臓や心臓の機能がサポートされ、全身の循環が改善されるとされます。 また、アルブミンは薬物の運搬にも重要な役割を果たしています。一部の薬剤はアルブミンに結合して血中で運搬されるため、アルブミンの濃度が変動すると、薬物の効果や副作用にも影響を与えることがあります。このため、薬物療法においてアルブミンのレベルを把握することは重要です。 アルブミンはまた、栄養管理においても重要です。特に、栄養不良や慢性炎症によりアルブミン濃度が低下することがあります。この場合、アルブミン濃度は患者の栄養状態の指標として利用されることがあります。病院では、アルブミンレベルをモニタリングし、必要に応じて栄養補助やアプローチを検討することがあります。 さらに、アルブミンは研究や診断においても利用されています。さまざまな疾患のバイオマーカーとしての役割もあり、心疾患や腎疾患、肝疾患などの早期発見に寄与します。最近では、アルブミンががん研究においても注目されており、腫瘍マーカーや治療効果の指標としての役割が期待されています。 アルブミンの製造においては、さまざまな技術が用いられています。例えば、血液からの分離や精製技術、細胞培養技術の発展により、アルブミン製剤の品質向上が図られています。また、遺伝子組換え技術を用いたアルブミンの開発も進められており、これにより、より安全で効果的な製剤が期待されています。 現在では、アルブミン製剤は多くの国で使用されており、その需要は年々増加しています。しかし、供給不足や高コスト、免疫反応に対する懸念などの課題も存在します。このため、アルブミンの代替物質や新たな製造方法の研究が進められている状況です。 このように、アルブミンは医療、薬物運搬、栄養管理、研究などのさまざまな分野で重要な役割を果たしています。今後もその機能や用途に関する研究が続けられ、さらなる発展が期待されています。アルブミンは私たちの健康にとって不可欠な存在であり、その理解を深めることは、医療や生物学の発展にとって重要です。アルブミンが担う多機能な役割は、今後の医療の進化においてますます注目されることでしょう。 |
